COMMACK, NY , March 19, 2018 (GLOBE NEWSWIRE) -- Patient Access Solutions, Inc. (OTC PINK: PASO), a provider of healthcare/financial processing and management solutions for the healthcare, and dental industries, proudly announces it has retained the services of Triumph Investor Relations, an experienced and successful Investor Relations Firm, to assist the Company to increase visibility to the investment community, improve shareholder communications, and expand media relations.
Our management team remains dedicated to transparency and protecting our shareholders. We will continue to demonstrate our commitment to the future of PASO through positive steps at improving our shareholder value via the retention of services from third parties that can assist the Company onto the road to success.
Triumph Investor Relations, Inc. is a national marketing public relations firm with a reputation for delivering results to clients who seek and appreciate the individual attention only a boutique agency can provide. With offices in New York and Florida it allows them the latitude to get PASO in front of an endless amount of industry professionals.
Bruce Weitzberg, CEO of Patient Access Solutions Inc., stated, “We are looking forward to the exposure and recognition that Triumph brings the table. Their team of professionals is an absolute asset to the growth of PASO.”
About Patient Access Solutions Inc.(www.pashealth.com)
Patient Access Solutions Inc. (PASHealth) is a Healthcare Solutions company which has created a formidable array of technology, management resources and allies to enable it to become an agent of radical change in what has traditionally been a slowly evolving healthcare environment. For more information about the services and products of Patient Access Solutions, please visit our website at www.pashealth.com.
About the CIIT Center (www.theciitcenter.com)
The CIIT Center occupies 12,500-square feet, in a street level office building located right off two major highways in Plainview, NY. The progressive center provides great efficiency and convenience in how we serve our patients. The goal is to create integrated, personalized treatment programs where the patient and staff work in unison to identify the underlying health conditions causing the issues, as opposed to just treating the symptoms.
About Triumph Investor Relations
Triumph utilizes a healthy mix of traditional grassroots campaigns and social media to ensure the results you need. The partners of Triumph have over 50 years’ experience in the industry and utilize their extensive rolodexes to benefit each of our portfolio companies. Our relationships with buy-side houses and research analysts from major investment banks have proven to be invaluable assets to the companies we support.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things, the following: general economic and business conditions; competition; unexpected changes in technologies and technological advances; ability to commercialize and manufacture products; results of experimental studies; research and development activities; changes in, or failure to comply with, governmental regulations; and the ability to obtain adequate financing in the future. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of Patient Access Solutions Inc. Securities and Exchange Commission filings available at http://www.sec.gov.